<DOC>
	<DOC>NCT02336659</DOC>
	<brief_summary>The aim of this study is to examine the effect of GLP-1 and other gut-secreted hormones (glucagon, GIP, grelin and PYY) on food-intake, appetite and glucose metabolism after Roux-en-Y gastric bypass surgery.</brief_summary>
	<brief_title>Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery</brief_title>
	<detailed_description>To do this the effect of combined GLP-1 receptor blockade by Exendin 9-39 and DPP-4-inhibition will be evaluated.</detailed_description>
	<mesh_term>Obesity, Morbid</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Uncomplicated RYGB performed 312 month proir to the study. Fasting plasma glucose &lt;7.0 mM and HbA1c &lt; 48 mmol/mol 3 month after RYGB. Fasting plasma glucose &gt;7.0 mM and HbA1c &gt; 48 mmol/mol 3 month after RYGB. Hemoglobin &lt;6.5mM. Previous anaphylaxis when treated with Januvia or Byetta. Allergy for sitagliptin. Dysregulated hypothyroidism. Use of antithyroid treatment. Late diabetic complications as retinopathy, renal insuffiency, neuropathy or previous pancreatitis. Bad compliance. Complications to RYGB: Documented reactive hypoglycaemia, severe dumping (with vomiting, diarrhea or severe abdominal pain after food intake).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>